The Italian Association of Medical Oncology recommendations on thymic epithelial tumors, which have been drawn up for the first time in 2020 through an evidence-based approach, report indications on all the main aspects of clinical management of this group of rare diseases, from diagnosis and staging, to new available systemic treatments, such as targeted therapies and immunotherapies. A summary of key recommendations is presented here and complete recommendations are reported as Supplementary Materials, available at https://doi.org/10.1016/j.esmoop.2021.100188.
Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM) / Conforti, F; Marino, M; Vitolo, V; Spaggiari, L; Mantegazza, R; Zucali, P; Ruffini, E; di Tommaso, L; Pelosi, G; Barberis, M; Petrini, I; Palmieri, G; Pasello, G; Galli, G; Berardi, R; Garassino, M; Filosso, P; Alloisio, M; Scorsetti, M; Orecchia, R; Pala, L; Abatedaga, L; Cinieri, S; De Pas, T. - In: ESMO OPEN. - ISSN 2059-7029. - 6:4(2021), p. 100188. [10.1016/j.esmoop.2021.100188]
Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM)
Berardi, R;
2021-01-01
Abstract
The Italian Association of Medical Oncology recommendations on thymic epithelial tumors, which have been drawn up for the first time in 2020 through an evidence-based approach, report indications on all the main aspects of clinical management of this group of rare diseases, from diagnosis and staging, to new available systemic treatments, such as targeted therapies and immunotherapies. A summary of key recommendations is presented here and complete recommendations are reported as Supplementary Materials, available at https://doi.org/10.1016/j.esmoop.2021.100188.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
